Clinical trial
A Study for Aggressive Adult T-cell Leukemia-lymphoma (ATLL)
NCT00145002 · Japan Clinical Oncology Group, Other · Completed
Key facts
| NCT number | NCT00145002 |
|---|---|
| Title | A Study for Aggressive Adult T-cell Leukemia-lymphoma (ATLL) |
| Official title | Phase III Study of VCAP-AMP-VECP vs. Biweekly CHOP in Aggressive Adult T-cell Leukemia-lymphoma (ATLL): Japan Clinical Oncology Group Study, JCOG9801. |
| Lead sponsor | Japan Clinical Oncology Group, Other |
| Collaborators | Ministry of Health, Labour and Welfare, Japan |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Adult T-cell Leukemia, Lymphoma |
| Intervention type | Drug |
| Interventions | VCAP-AMP-VECP with G-CSF and intrathecal prophylaxis, biweekly-CHOP with G-CSF and intrathecal prophylaxis |
| Enrollment | 130 |
| Start date | Aug 1, 1998 |
| Completion | Dec 1, 2004 |
| First posted | Sep 5, 2005 |
| Last update posted | Sep 22, 2016 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: